Search results for:
Steriwave shown to reduce resistant bacteria by >99.9%
Steriwave shown to reduce resistant bacteria by >99.9% Read article in The Microbiologist Vancouver, British Columbia, Canada - October 18, 2023 New research presented by Ondine shows that Steriwave photodisinfection reduces antibiotic-resistant bacteria by more than 99.9% without generating resistance. The research suggests [...]
Steriwave available coast-to-coast across Canada
Nova Scotia’s largest hospital is the latest to implement Steriwave nasal photodisinfection for use prior to orthopedic surgery Vancouver, British Columbia, Canada - October 13, 2023 Canadian life sciences company Ondine Biomedical’s (LON: OBI) Steriwave® nasal photodisinfection for the prevention of healthcare-associated infections (HAIs) is [...]
Ondine to present poster at IP2023 meeting, Liverpool
Ondine Biomedical will be presenting new research at the Infection Prevention Society 2023 Conference in Liverpool, UK Vancouver, British Columbia, Canada - October 10, 2023 Canadian life sciences company Ondine Biomedical Inc. (LON: OBI) will present results from a new in vitro study at the [...]
Penticton Hospital to adopt Steriwave as standard-of-care
Penticton Hospital to adopt Steriwave as standard-of-care Vancouver, British Columbia, Canada - October 9, 2023 Penticton Regional Hospital (PRH), located in the Okanagan area of British Columbia, has committed to implementing Canadian life sciences company Ondine Biomedical’s (LON: OBI) Steriwave® nasal photodisinfection technology as standard-of-care [...]
Burnaby Hospital deploys Steriwave
Burnaby Hospital in British Columbia has deployed Steriwave nasal photodisinfection to help prevent surgical site infections and optimize patient outcomes. Vancouver, British Columbia, Canada - September 29, 2023 Burnaby Hospital, a large community hospital in British Columbia, has initiated use of Ondine Biomedical’s (OBI:LON) [...]
Montreal Heart Institute pilots Steriwave
Second Quebec-based hospital pilots nasal photodisinfection to reduce antibiotic resistance Vancouver, British Columbia, Canada - September 21, 2023 The world-renowned Montreal Heart Institute and Hôpital Fleurimont, University of Sherbrooke (CHUS) in Sherbrooke, Quebec are piloting nasal photodisinfection to prevent post-operative infections in an era [...]
Steriwave proven highly effective against XDR bacteria
Ondine Biomedical presents research demonstrating high efficacy against Extensively Drug-Resistant (XDR) bacteria at ICPIC 2023, Geneva Vancouver, British Columbia, Canada - September 14, 2023 Canadian life sciences company Ondine Biomedical Inc. (LON: OBI) has presented new research at the 2023 International Consortium on Prevention & [...]
Steriwave evaluation at major heart institute
The evaluation at the Mazankowski Alberta Heart Institute in Edmonton, Canada, a world-leading centre for complex cardiac care and surgery, will see around 800 cardiac surgery patients treated with Steriwave in order to prevent surgical site infections (SSIs) Vancouver, British Columbia, Canada - September 12, 2023 [...]
Ondine to present new AMR research at ICPIC, Geneva
Ondine Biomedical to present new research on efficacy of photodisinfection against key gram-negative bacteria driving antimicrobial resistance threat Vancouver, British Columbia, Canada - August 29, 2023 Canadian life sciences company Ondine Biomedical Inc. will present new research on the efficacy of antimicrobial photodynamic therapy, known [...]
BBC News features first NHS pilot of Steriwave
BBC Look North evening news feature: A pioneering laser treatment which could cut the risk of drug-resistant infections after operations is being trialled for the first time in the UK. A six-month NHS pilot will see 500 patients given Ondine Biomedical's Steriwave® nasal photodisinfection at Pontefract Hospital in [...]
For Media Information
Simon Vane Percy
Amanda Bernard
